INSR and type 2 diabetes mellitus: In contrast to our data, CA at 5 and 10 mg/kg improved oral glucose tolerance tests and reduced fasting glucose in non-obese rats with T2DM induced by high-dose STZ [41] and enhanced insulin receptor signaling in FL83B liver cells [42].